This is the first renewal of Chemistry-Biology Interface (CBI) training grant T32 GM08804. We have designed an interdisciplinary program for training students (and faculty) at the interface of biological, medicinal, and traditional chemistry, called the Biological Chemistry Program (BCP). This program, which began in the fall of 2000, provides a focused, cross-disciplinary education for students interested in biological chemistry. The program is fully integrated into the three participating departments and students may obtain a degree in Chemistry, Biochemistry and Molecular Biophysics, or Pharmacology and Toxicology (Medicinal Chemistry Division) while following the Biological Chemistry Training Program. Students undertake coursework in all three departments, perform research rotations in at least two departments and participate in the weekly BCP research forum, where students and faculty present research results. Importantly, students may work with anyone in the program, regardless of departmental affiliation, allowing for true multi- disciplinary research efforts. The training faculty includes 34 highly-active research groups from four departments. Students remain active in the BCP until graduation. There are 36 students currently following the training program, 21 of which are training grant eligible;an additional 6-10 students are expected to join in the fall. Since inception in 2000, 8 students have completed the program with a PH.D. degree. Training grant slots are generally made for years 2 and 3 in the program, allowing training grant recipients great flexibility in assembling a multi-disciplinary research project. Fellowships are awarded near the end of the student's second semester, before they choose a thesis advisor, to assist in assembling a broad-based team. For years 6-10, we request 8 training grant slots per year, allowing for four 2-year fellowships to be awarded per year, and ~1/3 of our training-grant-eligible students to be funded at any given time. Training at the Chemistry-Biology Interface is highly relevant for advances in public health. Many of the most important discoveries occur at the intersection of one or more disciplines, where the knowledge of one field is brought to bear on the problems of another. By blending Chemistry, Medicinal Chemistry and Biochemistry, our trainees are poised to make the next breakthroughs in drug discovery, disease detection, disease prevention, and the discovery of the underlying causes of disease.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Fabian, Miles
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Arizona
Schools of Arts and Sciences
United States
Zip Code
Ma, Chunlong; Li, Fang; Musharrafieh, Rami Ghassan et al. (2016) Discovery of cyclosporine A and its analogs as broad-spectrum anti-influenza drugs with a high in vitro genetic barrier of drug resistance. Antiviral Res 133:62-72
Sinharay, Sanhita; Fernández-Cuervo, Gabriela; Acfalle, Jasmine P et al. (2016) Detection of Sulfatase Enzyme Activity with a CatalyCEST MRI Contrast Agent. Chemistry 22:6491-5
Fernández-Cuervo, Gabriela; Tucker, Kirsten A; Malm, Scott W et al. (2016) Diamagnetic Imaging Agents with a Modular Chemical Design for Quantitative Detection of β-Galactosidase and β-Glucuronidase Activities with CatalyCEST MRI. Bioconjug Chem :
Fernández-Cuervo, Gabriela; Sinharay, Sanhita; Pagel, Mark D (2016) A CatalyCEST MRI Contrast Agent that Can Simultaneously Detect Two Enzyme Activities. Chembiochem 17:383-7
Montfort, William R; Wales, Jessica A; Weichsel, Andrzej (2016) Structure and Activation of Soluble Guanylyl Cyclase, the Nitric Oxide Sensor. Antioxid Redox Signal :
Jensen, Stephanie M; Nguyen, Celina T; Jewett, John C (2016) A gradient-free method for the purification of infective dengue virus for protein-level investigations. J Virol Methods 235:125-30
Bartlett, Mitchell J; Joseph, Ria M; LePoidevin, Lindsey M et al. (2016) Long-term effect of sub-anesthetic ketamine in reducing L-DOPA-induced dyskinesias in a preclinical model. Neurosci Lett 612:121-5
Dowling, Daniel P; Miles, Zachary D; Köhrer, Caroline et al. (2016) Molecular basis of cobalamin-dependent RNA modification. Nucleic Acids Res 44:9965-9976
Guzman, Lindsay E; Kimani, Flora W; Jewett, John C (2016) Protecting Triazabutadienes To Afford Acid Resistance. Chembiochem 17:2220-2222
Jensen, Stephanie M; Kimani, Flora W; Jewett, John C (2016) Light-Activated Triazabutadienes for the Modification of a Viral Surface. Chembiochem 17:2216-2219

Showing the most recent 10 out of 52 publications